Eculizumab hypersensitivity and desensitization in a toddler with atypical hemolytic uremic syndrome

J Allergy Clin Immunol Pract. 2019 Sep-Oct;7(7):2409-2410. doi: 10.1016/j.jaip.2019.03.027. Epub 2019 Apr 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Atypical Hemolytic Uremic Syndrome / drug therapy
  • Child, Preschool
  • Complement Inactivating Agents / adverse effects*
  • Desensitization, Immunologic*
  • Drug Hypersensitivity / etiology
  • Drug Hypersensitivity / therapy*
  • Female
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • Complement Inactivating Agents
  • eculizumab